Skip to NavigationSkip to content

News

Based on a case split between the vaccine and placebo groups, the researchers said the therapy had shown an efficacy rate of 92% following the second...
Kate Bingham, the Head of the British Government’s vaccine taskforce, is facing further questions over a conflict of interest as a fund run by her...
Immune responses were greater in the higher dosage groups, and with response said to be comparable to that seen in patients who have recovered from...
Reopening hotels, gyms and restaurants carries the highest risk of spreading coronavirus, according to a new study.
The COVID-19 news this week focuses on vaccines, with AstraZeneca committing to an agreement to deliver 22 million doses of its COVID-19 vaccine...
The study found that the vaccine had an efficacy rate above 90% seven days following the second dose, 28 days after initial treatment.
It’s estimated that more than 1,000 treatment-naïve CLL patients will be eligible to access the therapy through this decision.
“This is welcome news for Scottish patients with prostate cancer. This new treatment is now available for a group of patients whose cancer has not...
The FDA has granted Emergency Use Authorization (EUA) to Eli Lilly’s antibody drug bamlanivimab for the treatment of COVID-19 patients who are not...
Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a severe adverse...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches